---
truth_dimension: planned
authority_level: authoritative
mutation_path: roadmap_update
---

# Phase 160 - Production-Path Alignment Checkpoint

Phase 160 reconciles the Phase 151-159 local beta product-capability block and remaps Phases 161-170 toward controlled internal trial packaging.

## Decision

`proceed_with_caveats_to_controlled_internal_trial_packaging`

This is readiness-not-approval: AJENTIC may plan and implement controlled internal trial packaging next, but Phase 160 does not approve production readiness, release readiness, Release Candidate status, Production Candidate status, deployment, publishing, signing, installer/update channels, public/general use, provider trust, action execution, or candidate approval.

## Phase 151-159 implementation reconciliation

| Phase | Evidence reconciled | Phase 160 finding |
| --- | --- | --- |
| 151 | Local session package artifact. | Present and carried forward for trial packaging input. |
| 152 | Session history and restore UI. | Present and carried forward for restore/history visibility. |
| 153 | Real local provider adapter contract. | Present as a constrained contract surface. |
| 154 | Controlled deterministic adapter dry-run harness. | Present as bounded dry-run evidence. |
| 156 | One constrained local provider invocation path. | Present without broad provider execution approval. |
| 157 | Provider output pipeline integration. | Present; provider output remains untrusted. |
| 158 | Local candidate materialization. | Present; local candidate materialization is not production approval. |
| 159 | Complete local operator workflow projection and UI. | Present; workflow completion is local beta only. |

## Current local beta workflow status

Current workflow status is aligned for controlled internal trial packaging input:

provider setup → constrained invocation → provider output pipeline → validation/review → staged proposal → staged validation → candidate review → operator decision → local candidate materialization → replay/status → evidence export → session package → restore/history.

## Remaining blockers for controlled internal trial packaging

| Blocker area | Phase 160 finding | Next mapped phase |
| --- | --- | --- |
| Trial package bundle | Missing product-facing controlled internal trial package/checklist bundle. | Phase 161 |
| Operator runbook/drilldowns | Runbook and failure drilldown surfaces need trial-operator usability. | Phase 162 |
| Trial evidence artifact | Trial-session evidence capture is not yet packaged as a local trial evidence artifact. | Phase 163 |
| Restore/replay verification | Trial package restore/replay verification needs executable deterministic proof. | Phase 164 |
| Trial execution harness | Broader internal trial execution needs bounded harness behavior after the first checkpoint. | Phase 166 |
| Trial observability/review | Trial failures, blocked states, evidence review, and unresolved blockers need local surfaces. | Phases 167-168 |
| Evidence-driven hardening | Confirmed trial defects need a hardening pass. | Phase 169 |

## Authority boundary preservation

| Boundary | Preserved Phase 160 statement |
| --- | --- |
| Local beta workflow | Local beta workflow completion is not production readiness. |
| Local candidate materialization | Local candidate materialization is not production approval. |
| Provider output | Provider output remains untrusted unless a later explicit bounded phase changes that. |
| Evidence export | Evidence export is not release evidence. |
| Session package | Session package is not a release artifact. |
| Restore projection | Restore projection is not recovery promotion. |
| Replay/status projection | Replay/status projection is not replay repair. |
| Operator decisions | Operator decisions are local workflow decisions, not release/deployment/public-use approvals. |
| Validation | Passing validation is not readiness approval. |
| Release readiness | Phase 160 is not release readiness approval. |
| Deployment | Phase 160 is not deployment approval. |
| Blocker review | Absence of blockers is not approval. |

## Phase 161 gate decision

Phase 161 may proceed as the next code-production phase: Controlled Internal Trial Package.

## Remapped Phase 161-170 block

| Phase | Title | Required product output |
| --- | --- | --- |
| 161 | Controlled Internal Trial Package | Local-only controlled internal trial package/checklist bundle for named internal trial operators. |
| 162 | Trial Operator Runbook and Failure Drill UI | Operator-facing runbook surfaces and visible failure/rejection drilldowns in the UI. |
| 163 | Trial Session Evidence Capture | Local trial-session evidence artifact. |
| 164 | Trial Replay and Restore Verification | Executable deterministic restore/replay verification. |
| 165 | Code-Production Alignment Checkpoint | Alignment-only reconciliation of Phases 161-164. |
| 166 | Controlled Internal Trial Execution Harness | Bounded internal trial workflow harness or deterministic local trial runner. |
| 167 | Trial Observability and Error Reporting | Local trial observability/error reporting surfaces. |
| 168 | Trial Evidence Review Surface | UI/evidence surface for trial evidence, operator notes, failure categories, and blockers. |
| 169 | Local Beta Hardening Pass | Evidence-driven local beta hardening fixes. |
| 170 | Production-Path Alignment Checkpoint | Alignment-only decision on Release Candidate preparation versus more hardening. |

Every non-0/5 phase must produce visible UI capability, executable Rust capability, persisted local artifact, restore/replay/export capability, trial package or trial evidence artifact, local observability/error-reporting capability, or end-to-end operator workflow improvement. Safety checks remain embedded in implementation phases and must not become the only product of a non-0/5 phase unless they directly validate a newly introduced executable capability.
